Aurgalys

News

• July 26, 2010: Aurgalys & CLS issue a new BioAlliance analyst note : Acyclovir Lauriad® to be registered in EU – Record turnover for S1 2010
• June 22, 2010: Aurgalys welcomes new partner and opens offices in Argentina
• April 7, 2010: Aurgalys-CLS reitarates BUY recommendation on BioAlliance stock [EuroNext: BIO.FP]

Meet Us At

• BioLatina 2010, October 18-20, 2010
• BioEquity Europe 2010, May 19-20, 2010
• 2010 BIO International Convention, May 3-6, 2010

Opinion

• July 10th, 2009: Venture capital and the French paradox
• March 16, 2009: Since 1997, FCPI funds have profoundly impacted on venture funding in France and Europe.
• Jan 21, 2009: »In France, in 2009, we expect up to two life science company take over ranging 75-200M € »

• Downloads

  Corporate Memorandum
  One Page Presentation
  

Comments are closed.

Search

• PAGES

  • Aurgalys
  • About Us
    • Aurgalys Team
    • Business Affiliate
    • Selected Customers
    • Memberships
  • Company Solutions & Services
    • Interim Management
    • Business Development
    • Corporate Finance
    • Management Assistance
    • Special Situations
  • Investor Solutions & Services
    • Due Diligence
    • Interim Management
    • Investor Assistance
  • Opinion
  • Meet Us At
  • News
  • Contact Us